Connecticut Attorney General William Tong has filed an appeal of a judge’s approval of Stamford-based Purdue Pharma’s bankruptcy plan.
The deal was slammed by Connecticut Attorney General William Tong, who is suing Purdue Pharma in state court.
Connecticut and the other dissenting states said talks with Purdue are progressing so they consented to extend a new, temporary halt to the lawsuits.
“Purdue is not entitled to enter bankruptcy as a means to evade responsibility for the suffering and death they have inflicted on our country,” said Connecticut Attorney General William Tong.
Dozens of drug companies, and others blamed for the opioid crisis may follow Purdue Pharma’s lead and try to settle claims against them.
Attorney General William Tong said the tentative settlement does not do enough to atone for the havoc wrecked by the opioid epidemic in Connecticut and across the nation.
In emails released Tuesday by Attorney General William Tong, Richard Sackler, the former president of Purdue Pharma, called drug users “victimizers” and said they are responsible for their own fate.
The amended lawsuit says Purdue and the Sacklers told doctors addiction was “not caused by drugs,” but instead was the result of “susceptible individuals.”
As Purdue Pharma considers bankruptcy to limit its liability, former Attorney General George Jepsen says states, not cities or towns, should pursue opioid lawsuits.
Sealed court documents show that a member of the Sackler family, which controls Stamford-based Purdue Pharma, agreed that the company should allow doctors to believe OxyContin was weaker than morphine.
Connecticut became the latest state on Thursday to sue Stamford-based Purdue Pharma, saying the company purposefully downplayed the risks of addiction of OxyContin and other opioid painkillers. Connecticut Attorney General George Jepsen said he sued in Superior Court because Purdue was not “serious about addressing the states’ very real allegations of misconduct and coming to a meaningful settlement.”
Updated at 10:15 a.m. with industry comment
WASHINGTON — Stamford-based Purdue Pharma, the maker of pain-killer OxyContin, is the target of an increasing number of suits by states, counties and cities alleging it is partly to blame for the nation’s opioid epidemic. The lawsuits are all different and some include other pharmaceutical companies and pharmacies as defendants. But Purdue is nearly always a main defendant.